Genomics Sells Nearly 30,000 Shares: Investor Signal for Genomics Stocks
A CEO’s large stock sale can spark questions about a company’s trajectory. This guide breaks down what genomics sells...
Which Is Better Retirement Index Fund Or Target Date Fund
A practical comparison of retirement index funds and target date funds, outlining when each may be the smarter pick for different retirement goals.
26,044 articlesVernova's Next Earnings Report Could Spark a Big Move
As vernova's next earnings report approaches, traders and long-term investors weigh margin trends, project momentum, ...
Hycroft Mining Stock Soaring: Key Investor Takeaways
Hycroft Mining stock is catching momentum as the company reports stronger gold and silver resources and clearer plans...
SOXX’s Next Months Hinge on Five Tech Giants’ CAPEX Outlook
The iShares Semiconductor ETF faces a pivotal year as AI-capex decisions by five hyperscalers set the pace. SOXX’s ne...
Lemonade's Improving Loss Ratio Is the Real Story Today
Lemonade has chased rapid growth, but the real investment signal is in its loss ratio. This article explains why lemo...
Palantir Revenue Surges 85%, Yet Stock Slips This Year
Palantir delivered an 85% year-over-year revenue surge in Q1 2026 and lifted full-year targets, but the shares are do...
Nike Analyst: 95% People Say Nike Is for Me, Others Lag
A Nike brand moat argument resurfaces as investors weigh the stock's downside and potential upside. A Nike analyst po...
Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Jolie-Pitt Reportedly Keeps Ties with Brad Pitt Family
Public rifts among celebrity families can complicate daily life and future planning. This piece examines how Pax Joli...
Costco's Cash Pile Building: Could a Special Dividend Arrive in 2026?
Costco has quietly stacked cash, raising questions about shareholder returns. This guide explains the potential for a...
Wedbush Lifts Apple Target to $400 on AI Inflection
Wedbush raises Apple’s price target to $400, arguing a coming AI shift could position Apple as the main AI distributi...
Altman Says Even CEOs Could Be Replaced by AI Soon
OpenAI CEO Sam Altman says AI could someday run a major company better than its human leadership, a warning that coul...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status